Truncated NPY-based NPY(Y1)R-specific radiopeptides: Improved in vivo PET tumor imaging by application of peptidase inhibitors
The neuropeptide Y receptor subtype 1 (NPY(Y1)R) exhibits high expression rates on human breast cancer and is therefore an important target structure for the sensitive and specific visualization and characterization of the disease by Positron Emission Tomography (PET). However, imaging of this recep...
Saved in:
Main Authors: | Benedikt Judmann (Author), Nils F. Baier (Author), Henning Rudolf (Author), Güllü Davarci (Author), Björn Wängler (Author), Ralf Schirrmacher (Author), Gert Fricker (Author), Carmen Wängler (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?
by: Alicia Vall-Sagarra, et al.
Published: (2018) -
Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11
by: Benedikt Judmann, et al.
Published: (2023) -
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
by: Benedikt Judmann, et al.
Published: (2020) -
Ultrasound-Assisted Solid-Phase Affibody Synthesis Using Z<sub>EGFR:1907</sub> as an Example-Superior to the Conventional Protocol?
by: Marie Prochiner, et al.
Published: (2024) -
Radiosynthesis of Stable <sup>198</sup>Au-Nanoparticles by Neutron Activation of α<sub>v</sub>β<sub>3</sub>-Specific AuNPs for Therapy of Tumor Angiogenesis
by: Güllü Davarci, et al.
Published: (2023)